Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Javid Moslehi

Showing results (21-30 of 148) with videos related to

Pageof 15
Sort By:
Hypertension (Dallas, Tex. : 1979)|March 22, 2017
Cardio-Oncology: Vascular Endothelial Growth Factor Inhibitors, Salt, and Macrophages: A Complicated InteractionJavid Moslehi, Arvind K Pandey, Nirmanmoh Bhatia
Nature Cardiovascular Research|August 28, 2024
PD-1-PD-L1 immunomodulatory pathway regulates cardiac regenerationJuan Qin, Guo N Huang, Javid Moslehi
Circulation|July 5, 2017
Grounding Cardio-Oncology in Basic and Clinical ScienceJavid Moslehi, Dulguun Amgalan, Richard N Kitsis
Vascular Medicine (London, England)|June 17, 2020
Vascular medicine and cardio-oncology - A new, evolving clinical frontierJorie Versmissen, John R Power, Javid Moslehi
Nature Reviews. Cardiology|April 20, 2022
Cardio-onco-metabolism: metabolic remodelling in cardiovascular disease and cancerAnja Karlstaedt, Javid Moslehi, Rudolf A de Boer
Circulation|January 14, 2020
Cardio-Immuno-OncologyVlad G Zaha, Wouter C Meijers, Javid Moslehi
Trends in Cardiovascular Medicine|January 8, 2013
Cardiovascular complications associated with novel angiogenesis inhibitors: emerging evidence and evolving perspectivesSteven M Bair, Toni K Choueiri, Javid Moslehi
Journal of the American College of Cardiology|September 27, 2014
Unravelling the causes of reduced peak oxygen consumption in patients with cancer: complex, timely, and necessaryGraeme J Koelwyn, Lee W Jones, Javid Moslehi
Hematology. American Society of Hematology. Education Program|December 10, 2017
Cardiovascular care of patients with chronic myeloid leukemia (CML) on tyrosine kinase inhibitor (TKI) therapyMary C Barber, Michael J Mauro, Javid Moslehi
Circulation Research|February 29, 2024
Ponatinib-Induced Cardiomyocyte Toxicity: Dark Side of the Integrated Stress ResponseFelix G Liang, Javid Moslehi, Richard N Kitsis
Pageof 15

Showing results (21-30 of 148) with videos related to

Sort By:
Pageof 15
Hypertension (Dallas, Tex. : 1979)|March 22, 2017
Cardio-Oncology: Vascular Endothelial Growth Factor Inhibitors, Salt, and Macrophages: A Complicated InteractionJavid Moslehi, Arvind K Pandey, Nirmanmoh Bhatia
Nature Cardiovascular Research|August 28, 2024
PD-1-PD-L1 immunomodulatory pathway regulates cardiac regenerationJuan Qin, Guo N Huang, Javid Moslehi
Circulation|July 5, 2017
Grounding Cardio-Oncology in Basic and Clinical ScienceJavid Moslehi, Dulguun Amgalan, Richard N Kitsis
Vascular Medicine (London, England)|June 17, 2020
Vascular medicine and cardio-oncology - A new, evolving clinical frontierJorie Versmissen, John R Power, Javid Moslehi
Nature Reviews. Cardiology|April 20, 2022
Cardio-onco-metabolism: metabolic remodelling in cardiovascular disease and cancerAnja Karlstaedt, Javid Moslehi, Rudolf A de Boer
Circulation|January 14, 2020
Cardio-Immuno-OncologyVlad G Zaha, Wouter C Meijers, Javid Moslehi
Trends in Cardiovascular Medicine|January 8, 2013
Cardiovascular complications associated with novel angiogenesis inhibitors: emerging evidence and evolving perspectivesSteven M Bair, Toni K Choueiri, Javid Moslehi
Journal of the American College of Cardiology|September 27, 2014
Unravelling the causes of reduced peak oxygen consumption in patients with cancer: complex, timely, and necessaryGraeme J Koelwyn, Lee W Jones, Javid Moslehi
Hematology. American Society of Hematology. Education Program|December 10, 2017
Cardiovascular care of patients with chronic myeloid leukemia (CML) on tyrosine kinase inhibitor (TKI) therapyMary C Barber, Michael J Mauro, Javid Moslehi
Circulation Research|February 29, 2024
Ponatinib-Induced Cardiomyocyte Toxicity: Dark Side of the Integrated Stress ResponseFelix G Liang, Javid Moslehi, Richard N Kitsis
Pageof 15